RT Journal Article
SR Electronic
T1 The Brief Observation of Symptoms of Autism (BOSA): Development of a New Adapted Assessment Measure for Remote Telehealth Administration through COVID-19 and Beyond
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.01.21265761
DO 10.1101/2021.11.01.21265761
A1 Dow, Deanna
A1 Holbrook, Alison
A1 Toolan, Christina
A1 McDonald, Nicole
A1 Sterrett, Kyle
A1 Rosen, Nicole
A1 Kim, So Hyun
A1 Lord, Catherine
YR 2021
UL http://medrxiv.org/content/early/2021/11/02/2021.11.01.21265761.abstract
AB Interest in telehealth assessment for autism has increased due to COVID-19 and subsequent expansion of remote psychological services, though options that are easy for clinicians to adopt and available through the lifespan are limited. The Brief Observation of Symptoms of Autism (BOSA) provides a social context with standardized materials and activities that can be coded by clinicians trained in the Autism Diagnostic Observation Schedule (ADOS). The current project examined psychometric properties to determine optimal use for each BOSA version. Three hundred and seven participants with 453 BOSAs were included to determine best performing items for algorithms, validity, sensitivity, specificity, recommended cut-offs, and proposed ranges of concern. While preliminary, the BOSA provides a promising new option for telehealth-administered assessment for autism.Competing Interest StatementCatherine Lord receives royalties from Western Psychological Services (WPS) for the ADOS-2, SCQ and ADI-R. The BOSA is copyrighted by WPS because of its overlap with the ADOS and BOSCC. Deanna Dow, Alison Holbrook, So Hyun Kim, and Catherine Lord are authors of the BOSA, but it is not currently for sale and does not yield any royalties at this time.Funding StatementThis study was supported by a grant from SFARI (811870, CL).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board of UCLA gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.